Skip to main content
. 2024 Sep 22;16(9):1498. doi: 10.3390/v16091498

Table 2.

Occurrence of Oropouche Virus (i.e., detection of either virus isolates or RNA) from samples collected from subjects with any sign/symptom of arbovirus infection.

Total Samples (N) OROV-Positive Cases (n/N, %) Risk Ratio (95%CI)
Overall 32,439 532, 1.64% -
Timeframe
Before 1990 344 92, 26.74% REFERENCE
1991–2010 21,178 19, 0.09% 0.003 (0.002; 0.005)
After 2010 10,917 421, 3.86% 0.144 (0.118; 0.175)
Country
Bolivia 2089 0, - 0.006 (0.001; 0.096)
Brazil 4030 162, 4.02% REFERENCE
Colombia 3067 105, 3.42% 0.852 (0.669; 1.084)
Ecuador 579 0, - 0.021 (0.001; 0.344)
French Guyana 95 23, 24.21% 6.023 (4.092; 8.864)
Haiti 1250 1, 0.08% 0.020 (0.003; 0.142)
Paraguay 340 0, - 0.037 (0.002; 0.586)
Peru 20,989 241, 1.15% 0.286 (0.235; 0.348)
Sample
Blood 32,152 525, 1.63% REFERENCE
CSF 287 7, 2.44% 1.494 (0.715; 3.120)
Diagnostic procedure
Virus isolation 946 138, 14.59% 4.347 (3.612; 5.231)
RT-qPCR 10,518 353, 3.36% REFERENCE
RT-qPCR + IFAT 20,880 18, 0.08% 0.026 (0.016; 0.041)
RT-qPCR + MNT 95 23, 24.21% 7.214 (4.981; 10.446)

Note: OROV = Oropouche Virus; 95%CI = 95% confidence interval; RT-qPCR = real-time polymerase chain reaction; CSF = cerebrospinal fluid; IFAT = indirect immunofluorescence assay; MNT = microneutralization test.